Pegylated (mw 20000) Human Sequence Recombinant
Pegylated (mw 20000) Human Sequence Recombinant Uses, Dosage, Side Effects, Food Interaction and all others data.
Pegylated (mw 20000) Human Sequence Recombinant is under investigation in clinical trial NCT02585960 (BAX 855 Pk-guided Dosing).
| Trade Name | Pegylated (mw 20000) Human Sequence Recombinant |
| Generic | PEGylated Recombinant Factor VIII |
| PEGylated Recombinant Factor VIII Other Names | Adynovate, Adynovi, Antihemophilic factor (recombinant), pegylated (20 kda), Antihemophilic factor (recombinant), pegylated (mw 20000), Antihemophilic factor, pegylated (mw 20000) human sequence recombinant, PEGylated Recombinant Factor VIII, Pegylated rfviii |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Pegylated (mw 20000) Human Sequence Recombinant
